企業プロフィール
Y-mAbs 株価・ニュース・カタリスト
- ティッカー:
- YMAB
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for YMAB.
企業概要
事業概要
Y-mAbs Therapeutics is an oncology and rare-disease company focused on antibody-based therapies. Its platform has been built around highly specific biologic treatments for difficult diseases.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Y-mAbs sits in specialty biotechnology.
ビジネスモデルの特徴
The company depends on product adoption, clinical progress, and the expansion of its antibody franchise.
バイオ業界での位置付け
Y-mAbs is a focused antibody biotech whose stock reacts to data, adoption, and label progress.
今後のカタリスト
- Y-mAbs’s catalysts are DANYELZA sales, pediatric-oncology expansion, and any follow-on immunotherapy update. The key question is whether the GD2 franchise can keep compounding.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。